Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 39

1.

Genetic variation at a single locus and age of onset for Alzheimer's disease.

Lutz MW, Crenshaw DG, Saunders AM, Roses AD.

Alzheimers Dement. 2010 Mar;6(2):125-31. doi: 10.1016/j.jalz.2010.01.011.

2.

Increased fibrillar amyloid-{beta} burden in normal individuals with a family history of late-onset Alzheimer's.

Mosconi L, Rinne JO, Tsui WH, Berti V, Li Y, Wang H, Murray J, Scheinin N, Någren K, Williams S, Glodzik L, De Santi S, Vallabhajosula S, de Leon MJ.

Proc Natl Acad Sci U S A. 2010 Mar 30;107(13):5949-54. doi: 10.1073/pnas.0914141107. Epub 2010 Mar 15.

3.

Whole genome association study of brain-wide imaging phenotypes for identifying quantitative trait loci in MCI and AD: A study of the ADNI cohort.

Shen L, Kim S, Risacher SL, Nho K, Swaminathan S, West JD, Foroud T, Pankratz N, Moore JH, Sloan CD, Huentelman MJ, Craig DW, Dechairo BM, Potkin SG, Jack CR Jr, Weiner MW, Saykin AJ; Alzheimer's Disease Neuroimaging Initiative..

Neuroimage. 2010 Nov 15;53(3):1051-63. doi: 10.1016/j.neuroimage.2010.01.042. Epub 2010 Jan 25.

4.

The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects.

Sleegers K, Lambert JC, Bertram L, Cruts M, Amouyel P, Van Broeckhoven C.

Trends Genet. 2010 Feb;26(2):84-93. doi: 10.1016/j.tig.2009.12.004. Epub 2010 Jan 18. Review.

PMID:
20080314
5.

A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease.

Roses AD, Lutz MW, Amrine-Madsen H, Saunders AM, Crenshaw DG, Sundseth SS, Huentelman MJ, Welsh-Bohmer KA, Reiman EM.

Pharmacogenomics J. 2010 Oct;10(5):375-84. doi: 10.1038/tpj.2009.69. Epub 2009 Dec 22.

6.

Vascular factors and markers of inflammation in offspring with a parental history of late-onset Alzheimer disease.

van Exel E, Eikelenboom P, Comijs H, Frölich M, Smit JH, Stek ML, Scheltens P, Eefsting JE, Westendorp RG.

Arch Gen Psychiatry. 2009 Nov;66(11):1263-70. doi: 10.1001/archgenpsychiatry.2009.146.

PMID:
19884614
7.

Parental history of Alzheimer disease associated with lower plasma apolipoprotein E levels.

van Vliet P, Westendorp RG, Eikelenboom P, Comijs HC, Frölich M, Bakker E, van der Flier W, van Exel E.

Neurology. 2009 Sep 1;73(9):681-7. doi: 10.1212/WNL.0b013e3181b59c2e.

8.

Hippocampal atrophy as a quantitative trait in a genome-wide association study identifying novel susceptibility genes for Alzheimer's disease.

Potkin SG, Guffanti G, Lakatos A, Turner JA, Kruggel F, Fallon JH, Saykin AJ, Orro A, Lupoli S, Salvi E, Weiner M, Macciardi F; Alzheimer's Disease Neuroimaging Initiative..

PLoS One. 2009 Aug 7;4(8):e6501. doi: 10.1371/journal.pone.0006501.

9.

The influence of parental history of Alzheimer's disease and apolipoprotein E epsilon4 on the BOLD signal during recognition memory.

Xu G, McLaren DG, Ries ML, Fitzgerald ME, Bendlin BB, Rowley HA, Sager MA, Atwood C, Asthana S, Johnson SC.

Brain. 2009 Feb;132(Pt 2):383-91. doi: 10.1093/brain/awn254. Epub 2008 Oct 1.

10.

Effect of parental family history of Alzheimer's disease on serial position profiles.

La Rue A, Hermann B, Jones JE, Johnson S, Asthana S, Sager MA.

Alzheimers Dement. 2008 Jul;4(4):285-90. doi: 10.1016/j.jalz.2008.03.009.

11.

Maternal family history of Alzheimer's disease predisposes to reduced brain glucose metabolism.

Mosconi L, Brys M, Switalski R, Mistur R, Glodzik L, Pirraglia E, Tsui W, De Santi S, de Leon MJ.

Proc Natl Acad Sci U S A. 2007 Nov 27;104(48):19067-72. Epub 2007 Nov 14.

12.

Effect of Alzheimer disease risk on brain function during self-appraisal in healthy middle-aged adults.

Johnson SC, Ries ML, Hess TM, Carlsson CM, Gleason CE, Alexander AL, Rowley HA, Asthana S, Sager MA.

Arch Gen Psychiatry. 2007 Oct;64(10):1163-71.

13.

Differential effects of aging and Alzheimer's disease on medial temporal lobe cortical thickness and surface area.

Dickerson BC, Feczko E, Augustinack JC, Pacheco J, Morris JC, Fischl B, Buckner RL.

Neurobiol Aging. 2009 Mar;30(3):432-40. Epub 2007 Sep 14.

14.

Imaging beta-amyloid burden in aging and dementia.

Rowe CC, Ng S, Ackermann U, Gong SJ, Pike K, Savage G, Cowie TF, Dickinson KL, Maruff P, Darby D, Smith C, Woodward M, Merory J, Tochon-Danguy H, O'Keefe G, Klunk WE, Mathis CA, Price JC, Masters CL, Villemagne VL.

Neurology. 2007 May 15;68(20):1718-25.

PMID:
17502554
15.

PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment.

Kemppainen NM, Aalto S, Wilson IA, Någren K, Helin S, Brück A, Oikonen V, Kailajärvi M, Scheinin M, Viitanen M, Parkkola R, Rinne JO.

Neurology. 2007 May 8;68(19):1603-6.

PMID:
17485647
16.

The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation.

Johnson SC, Schmitz TW, Trivedi MA, Ries ML, Torgerson BM, Carlsson CM, Asthana S, Hermann BP, Sager MA.

J Neurosci. 2006 May 31;26(22):6069-76.

17.
18.

Cytology and functionally correlated circuits of human posterior cingulate areas.

Vogt BA, Vogt L, Laureys S.

Neuroimage. 2006 Jan 15;29(2):452-66. Epub 2005 Sep 6.

19.

Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory.

Buckner RL, Snyder AZ, Shannon BJ, LaRossa G, Sachs R, Fotenos AF, Sheline YI, Klunk WE, Mathis CA, Morris JC, Mintun MA.

J Neurosci. 2005 Aug 24;25(34):7709-17.

20.

Cognitive impairment in preclinical Alzheimer's disease: a meta-analysis.

Bäckman L, Jones S, Berger AK, Laukka EJ, Small BJ.

Neuropsychology. 2005 Jul;19(4):520-31.

PMID:
16060827

Supplemental Content

Support Center